Suchergebnisse - "Letter"

PubPharm (5.702)

1

Effects of bortezomib on ponatinib-resistant Philadelphia chromosome-positive cells

enthalten in: Leukemia & lymphoma | 2024

von Okabe, S. | Moriyama, M. | Gotoh, A.

2

Inhibition of autophagy antagonizes breast cancer brain metastogenesis and augments the anticancer activity of lapatinib

enthalten in: Clinical and translational medicine | 2024

von Nawrocki, S. | Espitia, C. | Espinoza, M. | +6

3

Co-transcriptional R-loops-mediated epigenetic regulation drives growth retardation and docetaxel chemosensitivity enhancement in advanced prostate cancer

enthalten in: Molecular cancer | 2024

von Ying, Y. | Wu, Y. | Zhang, F. | +11

4

Venetoclax infectious risk score to identify patients with chronic lymphocytic leukemia at high infectious risk during venetoclax treatment : A multicenter SEIFEM study

enthalten in: American journal of hematology | 2024

von Autore, F. | Visentin, A. | Deodato, M. | +21

5

Cutaneous adverse events following treatment with third-generation EGFR tyrosine kinase inhibitors

enthalten in: Italian journal of dermatology and venereology | 2024

von Li Pomi, F. | Vaccaro, F. | Borgia, F. | +2

6

CXCR4 Antagonist in HPV5-Associated Perianal Squamous-Cell Carcinoma

enthalten in: The New England journal of medicine | 2024

von Marin-Esteban, V. | Molet, L. | Laganà, M. | +25

7

Asparaginase completion among adults including older patients with acute lymphoblastic leukemia treated with a modified DFCI protocol

enthalten in: Leukemia | 2024

von Perusini, M. | Andrews, C. | Eshetu, A. | +15

8

In Reply : Olanzapine for Chemotherapy-induced Nausea and Vomiting Pediatric Population: Take Home Message?

enthalten in: Journal of pediatric hematology/oncology | 2024

von Meena, J. | Gupta, A. | Jat, K.

9

Getting more bang for their buck : BCL2 inhibitors boost dendritic-cell function to enhance anti-cancer immune surveillance

enthalten in: Journal of translational medicine | 2024

von Montes-Gómez, A. | Tait, S.

10

Progression-Free Survival Gain : A Reliable Primary End Point for Drug Registration That Can Accelerate Patient Access to Urgently Needed Therapies

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2024

von Stewart, D. | Ramsay, T. | Navani, V. | +3

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[571]